Experts predict that FDC, a pharmaceutical company, may reach Rs 400 in the medium term, provided the stock closes above strong resistance at Rs 320. While it hit a 52-week high of Rs 322.70 on June 12, the stock is still showing positive signs, having rallied over 2% in a week and over 18% in the last three months.
